Back to top

Ucb Sa: (NA: UCBJF)

(U.S: NA) As of Apr 18, 2014 12:00 AM ET

 Add to portfolio

 ZacksTrade Now

$79.65 USD

0.00 (0.00%)

Volume: NA

Zacks Rank : 4-Sell [?]       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Quote Overview

Stock Activity

Open NA
Day Low NA
Day High NA
52 Wk Low NA
52 Wk High NA
Avg. Volume 42
Market Cap 15.49 B
Dividend 0.00 ( 0.00%)
Beta 0.53

Key Earnings Data

Forward PE 29.18
PEG Ratio 2.43
Current Qtr Est NA
Current Yr Est 2.73
Most Accurate Est NA
Qtr Earnings ESP[?] 0.00%
Exp Earnings Date NA
Prior Year EPS NA
Exp EPS Growth 12.00%
Industry MED-DRUGS

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for UCBJF

Zacks Rank [?] Sell 4
Zacks Industry Rank 51 / 265 (Top 19%)
Equity Research Report No Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
UCB SA UCBJF
BIO-PATH HLDGS BPTH
CELL THERAPEUT CTIC
ENANTA PHARMA ENTA
GRIFOLS SA-ADR GRFS
IMMUNOGEN INC IMGN
QUESTCOR PHARMA QCOR
SALIX PHARM-LTD SLXP
SUCAMPO PHARMAC SCMP
WUXI PHARMATECH WX

See all MED-DRUGS Peers>>